Caliper Buys Cambridge Research & Instrumentation for $20M

According to Caliper President and CEO Kevin Hrusovsky, the acquisition "extends the reach of Caliper's proprietary offerings along the in vitro to in vivo bridge by filling the gap in tissue analysis platforms."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories